153 related articles for article (PubMed ID: 23797814)
21. Insulin-like Growth Factor I Receptor: A Novel Target for Hepatocellular Carcinoma Gene Therapy.
Wang L; Yao M; Zheng W; Fang M; Wu M; Sun J; Dong Z; Yao D
Mini Rev Med Chem; 2019; 19(4):272-280. PubMed ID: 30360707
[TBL] [Abstract][Full Text] [Related]
22. IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
Tovar V; Alsinet C; Villanueva A; Hoshida Y; Chiang DY; Solé M; Thung S; Moyano S; Toffanin S; Mínguez B; Cabellos L; Peix J; Schwartz M; Mazzaferro V; Bruix J; Llovet JM
J Hepatol; 2010 Apr; 52(4):550-9. PubMed ID: 20206398
[TBL] [Abstract][Full Text] [Related]
23. Expression and Clinical Role of Cdc5L as a Novel Cell Cycle Protein in Hepatocellular Carcinoma.
Qiu H; Zhang X; Ni W; Shi W; Fan H; Xu J; Chen Y; Ni R; Tao T
Dig Dis Sci; 2016 Mar; 61(3):795-805. PubMed ID: 26553251
[TBL] [Abstract][Full Text] [Related]
24. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
Jernberg-Wiklund H; Nilsson K
Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
[TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I receptor tyrosine kinase inhibitor cyclolignan picropodophyllin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines.
Duan Z; Choy E; Harmon D; Yang C; Ryu K; Schwab J; Mankin H; Hornicek FJ
Mol Cancer Ther; 2009 Aug; 8(8):2122-30. PubMed ID: 19638450
[TBL] [Abstract][Full Text] [Related]
26. IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells.
Strömberg T; Ekman S; Girnita L; Dimberg LY; Larsson O; Axelson M; Lennartsson J; Hellman U; Carlson K; Osterborg A; Vanderkerken K; Nilsson K; Jernberg-Wiklund H
Blood; 2006 Jan; 107(2):669-78. PubMed ID: 16166596
[TBL] [Abstract][Full Text] [Related]
27. Induction of glutathione transferase in insulin-like growth factor type I receptor-overexpressed hepatoma cells.
Lee JY; Han CY; Yang JW; Smith C; Kim SK; Lee EY; Kim SG; Kang KW
Mol Pharmacol; 2007 Oct; 72(4):1082-93. PubMed ID: 17615245
[TBL] [Abstract][Full Text] [Related]
28. Cell surface GRP78 facilitates hepatoma cells proliferation and migration by activating IGF-IR.
Yin Y; Chen C; Chen J; Zhan R; Zhang Q; Xu X; Li D; Li M
Cell Signal; 2017 Jul; 35():154-162. PubMed ID: 28389416
[TBL] [Abstract][Full Text] [Related]
29. Caveolin-1 Confers Resistance of Hepatoma Cells to Anoikis by Activating IGF-1 Pathway.
Tang W; Feng X; Zhang S; Ren Z; Liu Y; Yang B; lv B; Cai Y; Xia J; Ge N
Cell Physiol Biochem; 2015; 36(3):1223-36. PubMed ID: 26138883
[TBL] [Abstract][Full Text] [Related]
30. Alpinetin suppresses proliferation of human hepatoma cells by the activation of MKK7 and elevates sensitization to cis-diammined dichloridoplatium.
Tang B; Du J; Wang J; Tan G; Gao Z; Wang Z; Wang L
Oncol Rep; 2012 Apr; 27(4):1090-6. PubMed ID: 22159816
[TBL] [Abstract][Full Text] [Related]
31. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
Charette N; De Saeger C; Lannoy V; Horsmans Y; Leclercq I; Stärkel P
Mol Cancer; 2010 Sep; 9():256. PubMed ID: 20860815
[TBL] [Abstract][Full Text] [Related]
32. Blockade of IGF-1 receptor tyrosine kinase has antineoplastic effects in hepatocellular carcinoma cells.
Höpfner M; Huether A; Sutter AP; Baradari V; Schuppan D; Scherübl H
Biochem Pharmacol; 2006 May; 71(10):1435-48. PubMed ID: 16530734
[TBL] [Abstract][Full Text] [Related]
33. Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells.
Zhang YC; Wang XP; Zhang LY; Song AL; Kou ZM; Li XS
World J Gastroenterol; 2006 Jul; 12(25):3977-82. PubMed ID: 16810743
[TBL] [Abstract][Full Text] [Related]
34. IGF-1R signaling is essential for the proliferation of cultured mouse spermatogonial stem cells by promoting the G2/M progression of the cell cycle.
Wang S; Wang X; Wu Y; Han C
Stem Cells Dev; 2015 Feb; 24(4):471-83. PubMed ID: 25356638
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
[TBL] [Abstract][Full Text] [Related]
36. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
Wang Z; Wei W; Sun CK; Chua MS; So S
Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of hepatocellular carcinoma cell growth by an anti-insulin-like growth factor-I receptor monoclonal antibody.
Yue L; Wang Y; Wang H; Gao H; Liang J; Sui A; Xiang J; Zhou F; Xu C; Zhao W; Liang W; Yao R
Oncol Rep; 2012 Oct; 28(4):1453-60. PubMed ID: 22895605
[TBL] [Abstract][Full Text] [Related]
38. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
39. [miR-143 inhibits proliferation and invasion of hepatocellular carcinoma cells via down-regulation of TLR2 expression].
Wang Y; Lu Z; Li Y; Ji D; Zhang P; Liu Q; Yao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1076-9. PubMed ID: 25270212
[TBL] [Abstract][Full Text] [Related]
40. The expression and effects the CABYR-c transcript of CABYR gene in hepatocellular carcinoma.
Li H; Fang L; Xiao X; Shen L
Bull Cancer; 2012 Mar; 99(3):E26-33. PubMed ID: 22285430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
